Dangerous Drug: Warfarin Sodium



Dangerous Drug: Warfarin Sodium





(war’ far in)

Apo-Warfarin (CAN), Coumadin, Gen-Warfarin (CAN), Jantoven

PREGNANCY CATEGORY X

PREGNANCY CATEGORY D

(USE WITH MECHANICAL HEART VALVES)


Drug Classes

Coumarin derivative

Oral anticoagulant


Therapeutic Actions

Interferes with the hepatic synthesis of vitamin K–dependent clotting factors (factors II-prothrombin, VII, IX, and X), resulting in their eventual depletion and prolongation of clotting times.


Indications



  • Venous thrombosis and its extension, treatment, and prophylaxis


  • Treatment of thromboembolic complications of atrial fibrillation (AF) with embolization, and cardiac valve replacement


  • PE treatment and prophylaxis


  • Prophylaxis of systemic embolization after acute MI



Available Forms

Tablets—1, 2, 2.5, 3, 4, 5, 6, 7.5, 10 mg; powder for injection—5 mg, reconstitutes to 2 mg/mL


Dosages

Dosage and administration must be individualized for each patient according to patient’s prothrombin time (PT) and INR response. Target of therapy is INR of 2–3 for AF, DVT, and PE or 2.5–3.5 for mechanical heart valve. IV use is reserved for situations in which oral warfarin is not feasible. Dosages are the same for oral and IV forms.


Dosages

Adults

Initially, 2–5 mg/day PO or IV. Adjust dosage according to patient response. For maintenance, 2–10 mg/day PO based on INR.

Geriatric patients

Lower doses are usually needed; begin with smaller doses than those recommended for adults, and closely monitor PT ratio or INR.


Pharmacokinetics
















Route Onset Peak Duration
Oral 1.5–3 days 2–5 days

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Dangerous Drug: Warfarin Sodium

Full access? Get Clinical Tree

Get Clinical Tree app for offline access